Net Cash Provided by (Used in) Financing Activities in USD of CITIUS ONCOLOGY, INC. from 2022 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CITIUS ONCOLOGY, INC. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2022 to 2024.
  • CITIUS ONCOLOGY, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was -$24.5M.
  • CITIUS ONCOLOGY, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $4.87M, a 193% increase from 2023.
  • CITIUS ONCOLOGY, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.66M, a 97.5% decline from 2022.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

CITIUS ONCOLOGY, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$24.5M 01 Jan 2024 31 Mar 2024 10-Q 20 May 2024

CITIUS ONCOLOGY, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.87M +$3.21M +193% 01 Oct 2023 30 Sep 2024 10-K 27 Dec 2024
2023 $1.66M -$66M -97.5% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024
2022 $67.7M 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.